Razadyne (Galantamine) - Drug Info, Side Effects, Research, Clinical TrialsRx drug information, pharmaceutical research, clinical trials, news, and more FDA Alerts Summary Description and Clinical Pharmacology Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Other Rx Information Active Ingredients Adverse Event Reports OBJECTIVE: To study the efficacy and safety of galantamine [generic for Razadyne] hydrobromide ER for the enhancement of cognition in non-demented Parkinson's patients (PD)... CONCLUSIONS: Contrary to our hypotheses, galantamine treatment did not improve attention/executive, memory or visuospatial performance in non-demented PD patients. Further, there was a high, statistically significant drop-out rate in the treatment group due to gastrointestinal side effects and self-reported worsening of PD symptoms. Treatment with galantamine did not enhance self-perception of mental sharpness or quality of life. No negative behavioural change such as hallucinations or apathy was found with treatment.
